Search Results - "Faber, Rowan"

Fundus Autofluorescence Change as an Early Indicator of Treatment Effect of Brachytherapy for Choroidal Melanomas by Navaratnam, Jesintha, Bærland, Thomas P., Eide, Nils A., Faber, Rowan T., Rekstad, Bernt L., Vavvas, Demetrios G., Bragadóttir, Ragnheiður

“…Background: Early confirmation of the effect of brachytherapy for choroidal melanoma showing that tumour coverage is valuable. The irradiated retinal pigment…”
Get full text

Characterizations of uveal melanoma patients with three additional primary malignancies by Eide, Nils Andreas, Faber, Rowan Thomas, Garred, Øystein, Sørum Falk, Ragnhild, Robsahm, Trude Eid

“…Purpose In a population‐based cohort of 960 uveal melanoma (UM) patients, we describe patients with three additional malignancies, including one unique patient…”
Get full text

Primary vitrectomy or intravitreal antibiotics followed by early vitrectomy for acute endophthalmitis: A prospective observational study by Blom, Kathrine, Jørstad, Øystein Kalsnes, Faber, Rowan Thomas, Stene‐Johansen, Ingar, Holberg‐Petersen, Mona, Hermansen, Nils Olav, Bragadóttir, Ragnheiður

“…Background/aims To compare outcomes of acute endophthalmitis (EO) managed with either primary vitrectomy (PV) or primary intravitreal antibiotics (vancomycin…”
Get full text

Disseminated tumour cells in bone marrow of patients with uveal melanoma by Eide, Nils, Hoifødt, Hanne K., Nesland, Jahn M., Faye, Ragnar S., Qvale, Geir A., Faber, Rowan T., Jebsen, Peter, Kvalheim, Gunnar, Fodstad, Øystein

“… Purpose:  Approximately 50% of patients with uveal melanomas develop metastases. Thus, it is important to improve our understanding of how melanoma…”
Get full text

Two‐year functional and anatomical results after converting treatment resistant eyes with exudative age‐related macular degeneration to aflibercept in accordance with a treat and extend protocol by Jørstad, Øystein Kalsnes, Faber, Rowan Thomas, Moe, Morten Carstens

“…Purpose To study the effects of converting to aflibercept in accordance with a treat and extend (T&E) strategy in eyes with treatment resistant exudative…”
Get full text

Initial improvements when converting eyes with treatment‐resistant exudative AMD to aflibercept are substantially diminished after increasing treatment intervals from 4 to 8 weeks by Jørstad, Øystein Kalsnes, Faber, Rowan Thomas, Moe, Morten Carstens

Get full text

Macular hole Delphi consensus statement (MHOST) by Confalonieri, Filippo, Haave, Hanna, Binder, Susanne, Bober, Agnieszka Monika, Bragadottir, Ragnheidur, Baerland, Thomas, Faber, Rowan, Forsaa, Vegard, Gonzalez-Lopez, Julio J, Govetto, Andrea, Haugstad, Marta, Ivastinovic, Domagoj, Jenko, Neža Čokl, Nicoară, Simona Delia, Kaljurand, Kuldar, Kozak, Igor, Kvanta, Anders, Lytvynchuk, Lyubomyr, Nawrocka, Zofia Anna, Pajic, Sanja Petrovic, Petrovič, Mojca Globočnik, Radecka, Liga, Rehak, Matus, Romano, Mario R, Ruban, Andrii, Speckauskas, Martynas, Stene-Johansen, Ingar, Stranak, Zbynek, Thaler, Angela, Thein, Anna Sophie Aagaard, Theocharis, Ioannis, Tomic, Zoran, Yan, Xiaohe, Zekolli, Muhamet, Zhuri, Burim, Znaor, Ljubo, Petrovski, Beata Eva, Kolko, Miriam, Lumi, Xhevat, Petrovski, Goran

“…To derive a Delphi method-based consensus for the surgical management of Full Thickness Macular Hole (FTMH) and Lamellar Macular Hole (LMH). 37 expert VR…”
Get full text

The Results of Stricter Inclusion Criteria in an Immunomagnetic Detection Study of Micrometastatic Cells in Bone Marrow of Uveal Melanoma Patients - Relevance for Dormancy by Eide, Nils, Faye, Ragnar S., Høifødt, Hanne K., Sandvik, Leiv, Qvale, Geir A., Faber, Rowan, Jebsen, Peter, Kvalheim, Gunnar, Fodstad, Øystein

“…Approximately 50% of uveal melanoma patients develop metastases. We want to evaluate the effect of stricter criteria on our data from our previous study…”
Get full text

Immunomagnetic detection of micrometastatic cells in bone marrow of uveal melanoma patients: a paradox by Eide, Nils, Faye, Ragnar S., Høifødt, Hanne K., Sandstad, Berit, Qvale, Geir, Faber, Rowan, Jebsen, Peter, Kvalheim, Gunnar, Fodstad, Øystein

“…Purpose Our objective was to study survival rates with the bone marrow (BM) results in a cohort of uveal melanoma patients with long follow‐up. Methods…”
Get full text